Tranzyme - Crunchbase Company Profile & Funding

Q: Who invested in Tranzyme?

Tranzyme has 7 investors including H.I.G. Capital And BDC Venture Capital.

Q: When was the last funding round for Tranzyme?

Tranzyme closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Tranzyme raised to date?

Tranzyme has raised obfuscated.

Overview

Tranzyme

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Tranzyme

Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies.

Closed

Founded

obfuscation

Private

Venture - Series Unknown

Durham, North Carolina, United States

11-50

www.tranzyme.com

Biotechnology

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Michael Wasserman: Bord of Directors
Past Role: Advanced Therapeutics, Director of Research

Details

Legal Name

Tranzyme, Inc

Operating Status

Closed

Company Type

For Profit

About the Company

Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies. The company currently has programs for gastrointestinal motility disorders and retains worldwide rights for these programs. The company’s product portfolio includes, TZP-101, for the treatment of post-operative

ileus and severe gastroparesis; and TZP-301, for the treatment of obesity and metabolic syndrome.

Tranzyme Pharma is based in North Carolina, United States.

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tranzyme	4	obfuscated obfuscation	BDC Venture Capital, H.I.G. Capital, Quaker BioVentures, Thomas, McNerney & Partners	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
H.I.G. Capital	Yes	Venture Round - Tranzyme	—
H.I.G. Capital	Yes	Venture Round - Tranzyme	—
H.I.G. Capital	Yes	Venture Round - Tranzyme	—
H.I.G. Capital	Yes	Venture Round - Tranzyme	—
H.I.G. Capital	Yes	Venture Round - Tranzyme	—